That's the main thing I had to get past to invest on bios, especially bios with great cancer results. I do believe that the FDA and big Pharma as a whole have been holding back progress since the FDA was formed, but I also think that technology and medicine have evolved to the point where they just can't do it anymore without the public catching on. Think about it, how could they possibly justify rejecting immunopulse, a treatment that shrinks 90-95% of all rumors it is applied to, creates a distant response in about 60% of patients and it does all this without ANY drug related adverse events. You've also got to remember that they have already approved a drug (yervoy) that is far more effective than chemo but also has serious safety issues(I think I read somewhere that 6.5 % of patients died from the treatment). Also, I think, though I haven't looked into it, that the big pharmas who are developing these checkpoint inhibitors also make plent of money selling chemo drugs. It's clear that they see that the future of oncology and likely medicine as a whole is immune therapy.
News 
Market Data 
Discover 
